Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Archives of Neurology|November 1, 1994
Serum cobalamin deficiency is uncommon in multiple sclerosisD E Goodkin, D W Jacobsen, N Galvez, et al.Archives of Neurology|August 2, 2001
Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosisD C Mohr, D E Goodkin, J Islar, et al.Neurology|May 10, 2000
Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1aM Kita, D E Goodkin, P Bacchetti, et al.Magnetic Resonance Imaging|December 7, 2002
3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brainD Pelletier, S J Nelson, D Grenier, et al.Neurology|April 1, 1992
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research GroupD E Goodkin, D Cookfair, K Wende, et al.Neurology|November 1, 1996
Low-dose oral methotrexate in chronic progressive multiple sclerosis: analyses of serial MRIsD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.Magnetic Resonance Imaging|February 20, 2003
T2 relaxation time histograms in multiple sclerosisD Grenier, D Pelletier, M Normandeau, et al.Journal of Behavioral Medicine|August 1, 1997
Identification of Beck Depression Inventory items related to multiple sclerosisD C Mohr, D E Goodkin, W Likosky, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
1H MRSI of normal appearing white matter in multiple sclerosisW D Rooney, D E Goodkin, N Schuff, et al.Archives of Neurology|May 1, 1997
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosisD C Mohr, D E Goodkin, W Likosky, et al.Pageof 8